Where do Design Therapeutics, Inc.'s ratios come from?

Every ratio is computed from Design Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Returns
Return on equity	-30.7%-11.6pp	-19.1%+3.0pp	-22.1%-4.3pp	-17.8%—
Return on assets	-29.2%-10.9pp	-18.3%+2.9pp	-21.2%-3.9pp	-17.3%-0.7pp
Return on invested capital	-37.9%-12.0pp	-25.9%+1.8pp	-27.7%+6.8pp	-34.5%—
Efficiency
Asset turnover	0×—	0×—	——	——
Liquidity
Current ratio	17.1×-12.2×	29.3×-0.3×	29.6×-1.5×	31.1×-41.9×
Quick ratio	17.1×-12.2×	29.3×-0.3×	29.6×-1.5×	31.1×-41.9×
Cash ratio	1.3×-1.4×	2.7×+0.5×	2.2×-0.3×	2.5×-54.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$3.71-13.4%	$4.28-13.7%	$4.96-15.6%	$5.88-29.4%
Valuation
Market capitalization	$839.42M+295%	$349.35M+135%	$148.35M-74.1%	$573.17M-51.8%
Enterprise value	$829.39M+313%	$329.12M+153%	$130.2M-76.3%	$550.36M-38.4%
Price / book	3.8×+2.9×	1.4×+0.9×	0.5×-1.2×	1.8×-1.4×
Free cash flow yield	-6.4%+16.0pp	-12.4%+27.2pp	-39.6%-30.5pp	-9.1%-6.5pp
Earnings yield	-8.3%+18.2pp	-14.2%+30.9pp	-45.1%-34.0pp	-11%-8.1pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Design Therapeutics, Inc.'s ratios come from?: Every ratio is computed from Design Therapeutics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.